No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
AGN Argenica Therapeutics Ltd
- 0.645
- +0.035+5.74%
20min DelayMarket Closed Dec 24 10:48 AET
82.62MMarket Cap-12.17P/E (Static)
0.645High0.630Low12.31KVolume0.630Open0.610Pre Close7.91KTurnover0.98552wk High0.01%Turnover Ratio128.09MShares0.46552wk Low-0.053EPS TTM59.04MFloat Cap1.020Historical HighLossP/E (Static)91.53MShs Float0.250Historical Low-0.053EPS LYR2.46%Amplitude--Dividend TTM5.92P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Argenica Therapeutics' Phase 2 Stroke Drug Trial Hits Major Milestone | ASX:AGN, OTC:OTCMKTS: AGNTF
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Argenica Therapeutics Ltd (AU:AGN) and Bio-Rad Laboratories (BIO)
Argenica Therapeutics Posts Positive Studies Results Required by US FDA for IND Application, Says Euroz Hartleys
Petra Capital Keeps Their Buy Rating on Argenica Therapeutics Ltd (AGN)
We Think Argenica Therapeutics (ASX:AGN) Can Afford To Drive Business Growth
Argenica Therapeutics Ltd: Appendix 4E & Annual Report to 30 June 2024
Trending AU Stocks
ASX High Dividend ASX High Dividend